Highland Capital Management (Texas)’s Acorda Therapeutics ACOR Stock Holding History

Highland Capital Management (Texas)’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$119K	Sell	129 -84	-39%	-$103K	0.01%	309
2019 Q1	$339K	Buy	213 +84	+65%	+$151K	0.02%	265
2018 Q4	$241K	Hold	129	–	–	0.02%	244
2018 Q3	$305K	Hold	129	–	–	0.02%	273
2018 Q2	$445K	Hold	129	–	–	0.03%	217
2018 Q1	$367K	Hold	129	–	–	0.02%	260
2017 Q4	$332K	Hold	129	–	–	0.02%	251
2017 Q3	$367K	Buy	+129	New	+$340K	0.02%	236

Other funds holding ACOR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Highland Capital Management (Texas)'s ACOR Position: Q2 2019 in Review

Highland Capital Management (Texas) reduced its Acorda Therapeutics (ACOR) stake by 39% in Q2 2019, selling an estimated $103K and leaving 129 shares worth $119K. The position accounts for 0.01% of the portfolio, ranked #309.

Highland Capital Management (Texas) first reported a position in ACOR in Q3 2017 and has held it in 8 quarters since. The position peaked at $445K in Q2 2018. 163 funds tracked by Wall St. Rank hold ACOR as of Q2 2019.

Highland Capital Management (Texas) held 129 shares of Acorda Therapeutics worth $119K as of Q2 2019.
Highland Capital Management (Texas) sold 84 Acorda Therapeutics shares in Q2 2019, an estimated $103K.
Acorda Therapeutics made up 0.01% of Highland Capital Management (Texas)'s portfolio in Q2 2019, its #309 holding.
Highland Capital Management (Texas) first reported a position in Acorda Therapeutics in Q3 2017 and has held it in 8 quarters since.
Highland Capital Management (Texas)'s Acorda Therapeutics position peaked at $445K in Q2 2018.
163 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.